Zongxiu Zhang
Overview
Explore the profile of Zongxiu Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
431
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang H, Zhang Z, Hongpaisan J
Front Aging Neurosci
. 2024 Jan;
15:1272361.
PMID: 38187357
Background: Current evidence suggests that microvessel disease is involved in Alzheimer's disease (AD). Cerebrovascular disease correlates with cardiovascular disease and is complicated in ≈40% of AD patients. The protein kinase...
2.
Wang H, Zhang Z, Sittirattanayeunyong S, Hongpaisan J
Neuroscience
. 2023 Jun;
526:204-222.
PMID: 37385335
Current data suggest a hypothesis of vascular pathogenesis for the development and progression of Alzheimer's disease (AD). To investigate this, we studied the association of apolipoprotein E4 (APOE4) gene on...
3.
Sharma A, Wang H, Zhang Z, Millien G, Tyagi M, Hongpaisan J
Mol Neurobiol
. 2022 Jun;
59(8):4966-4986.
PMID: 35665894
Current evidence suggests that mild cerebrovascular changes could induce neurodegeneration and contribute to HIV-associated neurocognitive disease (HAND) in HIV patients. We investigated both the quantitative and qualitative impact of HIV...
4.
Millien G, Wang H, Zhang Z, Alkon D, Hongpaisan J
Front Aging Neurosci
. 2022 Mar;
14:836634.
PMID: 35299945
Vascular endothelial dysfunction and capillary loss are currently considered to be a primary phenotype of normal human aging and Alzheimer's disease (AD). Activation of protein kinase C (PKCε) improves several...
5.
Jin X, Zimmers T, Zhang Z, Koniaris L
Dig Dis Sci
. 2018 Oct;
64(1):93-101.
PMID: 30284135
Introduction: Loss of hepatic epidermal growth factor receptor (EGFR) expression is a cause for the increased perioperative risk for complications and death in patients with obesity and fatty liver undergoing...
6.
Jin X, Zimmers T, Jiang Y, Milgrom D, Zhang Z, Koniaris L
Surgery
. 2018 Jan;
163(6):1264-1271.
PMID: 29361369
Background: Patients with fatty liver have delayed regenerative responses, increased hepatocellular injury, and increased risk for perioperative mortality. Currently, no clinical therapy exists to prevent liver failure or improve regeneration...
7.
Zimmers T, Jin X, Zhang Z, Jiang Y, Koniaris L
Am J Physiol Endocrinol Metab
. 2017 Jun;
313(4):E440-E449.
PMID: 28655714
Hepatic steatosis is a common histological finding in obese patients. Even mild steatosis is associated with delayed hepatic regeneration and poor outcomes following liver resection or transplantation. We sought to...
8.
Bonetto A, Aydogdu T, Jin X, Zhang Z, Zhan R, Puzis L, et al.
Am J Physiol Endocrinol Metab
. 2012 Jun;
303(3):E410-21.
PMID: 22669242
Cachexia, the metabolic dysregulation leading to sustained loss of muscle and adipose tissue, is a devastating complication of cancer and other chronic diseases. Interleukin-6 and related cytokines are associated with...
9.
Jin X, Zimmers T, Zhang Z, Pierce R, Koniaris L
Gut
. 2008 Dec;
59(2):186-96.
PMID: 19074180
Background And Aims: Interleukin-6 (IL-6) is a well-recognised mediator of liver disease and regeneration. However, the in vivo effects of IL-6 on enterocytes and the intestinal tract have not been...
10.
Jin X, Zhang Z, Beer-Stolz D, Zimmers T, Koniaris L
Hepatology
. 2007 Aug;
46(3):802-12.
PMID: 17668886
Unlabelled: Extreme hepatectomy or resection of more than 80% of liver mass often leads to liver failure and death and is a major limitation to therapeutic liver resection for patients...